Osteosarcoma typically presents with primary site pain. The authors report a case of extensive metastatic osteosarcoma without any complaint of primary site pain during initial presentation. The 23-year-old female patient presented with simultaneous multiple cervical, supraclavicular, and axillary lymphadenopathy, as well as two large subcutaneous fat tumours. Despite initial excision biopsy of cervical lymph nodes, the diagnosis of osteosarcoma was only clinched after open biopsy of the right distal femur lesions and further histological evaluation. Though the patient was promptly started on neo-adjuvant chemotherapy and achieved excellent histological response to treatment, the disease had relapsed quickly and she succumbed to the disease one year after initial presentation. This report highlights the need to be vigilant in the workup and investigation of osteosarcoma, as the presenting symptoms may be more heterogenous than the conventional teaching of primary site pain.
INtRODUCtION
Osteosarcoma is the most common primary bone malignancy in children and young adults 1 . It is defined as a maglinant mesenchymal neoplasm in which the tumour cells produce defective and immature bone (osteoid) 2 . It has a male-to-female ratio between 1.5:1 and 2:1, with a bimodal age distribution: in the second decade of life and another late peak in the sixth decade of life 1, 3, 4 . The metaphysis of long tubular bones is most frequently affected, especially along the distal femur. The proximal tibia and humerus are also commonly involved, followed by the proximal femur and pelvis 3, 4 .
The pathogenesis of osteosarcoma involves an abnormality in the tumour supressor genes retinoblastoma (Rb) or Li-Fraumeni syndrome (p53). While patients with hereditary retinoblastoma have several hundred-fold greater risk of developing osteosarcoma, germline mutations of the p53 gene are more frequently seen in sporadic osteosarcoma 2 .
Classification of the disease is complex and more than 12 different subtypes have been described. The World Health Organization (WHO) classification recognises three major subtypes of high-grade intramedullary osteosarcoma (conventional osteosarcoma): osteoblastic, condroblastic, and fibroblastic, reflecting the predominant type of matrix within the tumour. Other histological variants include low-grade intramedullary osteosarcoma, parosteal osteosaroma, periosteal osteosarcoma, high-grade surface osteosarcoma, telangiectatic osteosarcoma, small cell osteosarcoma, and secondary osteosarcoma in Paget disease 5 .
Metastatic disease occurs in up to 30% of patients diagnosed with osteosarcoma and common metastatic sites are to the lungs, bones, regional lymph nodes, and visceral organs (heart, liver, pancreas, small bowel) 6 . Peritoneal, skeletal muscles, subcutaneous fat, and cutaneous metastases are very rare 7, 8 .
Despite its simple definition, the clinical behaviour of osteosarcoma remains highly heterogenous.
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As osteosarcoma typically presents with primary site pain, an initial presentation of synchronous multifocal disease can lead to misdiagnosis and subsequently delays to the initiation of appropriate therapy. The authors report a case of atypical presentation of osteosarcoma in a 23-year-old Chinese woman who initially presented with simultaneous multiple cervical, supraclavicular and axillary lymphadenopathy, and two large subcutaneous fat tumours. She did not report any pain in the primary site on initial presentation. 90º. Her serum alkaline phosphatase and lactate dehydrogenase were highly elevated at 634 U/L and 895 U/L respectively. However, her serum calcium level was normal.
CASE REPORt
Radiographic films of her right knee showed patchy sclerotic areas at the distal femur with associated periosteal reaction, highly suspicious of bone forming sarcoma. There was also a calcified opacity behind the femur in the posterior popliteal fossa. Pelvic film showed two bony lesions over the right iliac bone posteriorly, in keeping with osteoblastic metastases. Magnetic resonance imaging (MRI) of her right thigh and knee was ordered, which revealed extensive tumour involvement of the right mid to distal femur including the medial and lateral condyles, as well as the right proximal tibia, the posterior popliteal fossa and right gluteal soft tissue (Fig. 1a) .
The largest lesion at the right distal femur was biopsied. Open biopsy of this lesion revealed malignant osteoblastic epitheloid mesenchymal neoplasm suggestive of osteosarcoma. Histological findings included large, epitheloid cells with ample but retracted cytoplasm. The nuclei had irregular contours with hyperchromasia and focal pleomorphism. Intercellular production of eosinophilic osteoid was seen. The neoplastic cells were uniformly immunopositive for vimentin, with the presence of spotty CD56 immunoreactivity suggestive of osteoblastic differentiation ( Fig. 2  and 3 ).
Having identified the primary lesion, the disease was staged by computed axial tomography (CAT) which showed multiple bilateral enlarged cervical, supraclavicular, axillary and mediastinal lymph nodes. The larger nodes measured up to 2 cm. CAT scans of the thorax/abdomen/pelvis revealed several scattered small pulmonary opacities and soft tissue nodules in the subcutaneous fat of the anterior abdominal wall, the right gluteal region and in the properitoneal fat adjacent to the ascending colon (Fig. 1b and 1c) .
Radionuclide bone scan identified a primary osteogenic malignancy at the right distal femur, synchronous bone metastases to the condylar region of the right tibia and the right iliac bone, multiple lymph nodes metastases to the cervical, supraclavicular and axillary region, as well as metastases to the left lung posteriorly (Fig. 1d) .
Neo-adjuvant chemotherapy was commenced from the third month of presentation. She underwent four cycles of neo-adjuvant doxorubicin/cisplatin over the next two months. Post-neo-adjuvant chemotherapy treatment, the patient reported improvement in pain over the right knee and reduction in size of the subcutaneous nodules at the epigastric region and right gluteal region. Repeat MRI of the right thigh and knee, CAT of the neck, thorax/abdomen/pelvis were also done. The metastatic deposits did not progress in terms of size or numbers and decision was made for curative surgical resection.
At six months after her initial presentation, she underwent wide resection of the right distal femoral osteosarcoma with a megaprosthesis reconstruction of the right lower limb. Histology of the resected distal femoral and proximal tibial bones revealed favourable outcomes in terms of tumour necrosis response to chemotherapy. The primary osteoblastic osteosarcoma in the right distal femur showed more than 90% tumour necrosis; tissue from the right proximal tibia showed 100% tumour necrosis, and tissue from the posterior popliteal fossa also showed 100% tumour necrosis.
She received another two cycles of doxorubicin/ cisplatin at two and three months post-surgery. A repeat CAT scan done after the completion of six cycles of chemotherapy revealed an increase in size of the ossified cervical, supraclavicular, axillary, and mediastinal lymph nodes, as well as the ossified subcutaneous metastatic deposits. She was subsequently started on another two cycles of second line chemotherapeutic agents: ifosfamide and etoposide. The CAT scans performed after completion of the second cycle of second line chemotherapy continued to show progressive disease with increase in size of metastatic deposits in the neck, chest, and subcutaneous fat. She eventually succumbed to the disease one year after the initial presentation.
DISCUSSION
This patient had extensive metastatic disease including multiple bilateral lungs metastases, bone metastases to the right iliac bone, right knee joint involvement with skip lesions to the right proximal femur and right proximal tibia, multiple cervical, supraclavicular, axillary and mediastinal lymph nodes metastases, subcutaneous fat metastases to the anterior abdominal wall and right gluteal region, as well as properitoneal fat metastases. Her clinical presentation was similar to synchronous multifocal osteosarcoma but with lungs metastases 9 .
Multifocal osteosarcoma accounts for 1-2% of all osteosarcomas and can be classified into two types: synchronous and metachronous [10] [11] [12] . The synchronous type is defined as multiple lesions that appear to develop within six months 12 . This disease subtype generally arises in younger patients and is typically sclerotic on radiographic and histological evaluation 13 . In the past, there was much debate on whether synchronous multifocal osteosarcoma represents multiple primary tumours or metastatic disease. The idea of multiple primary tumours was favoured initially but more recent reviews concluded that it is a metastatic process instead 14, 15 . Arguments that supported a metastatic pathogenesis include a single dominant lesion; bone-to-bone metastases via venous plexuses or intraosseous embolisation; lymphatic spread; clinical and/or radiological underestimation of lung metastases, and a similar chemotherapy response in the primary tumour and the synchronous lesions 16 .
Metastatic disease occurs in up to 30% of patients diagnosed with osteosarcoma and distant spread
Proceedings of Singapore Healthcare  Volume 22  Number 4  2013 to the lung accounts for 80% of metastatic cases 6 . While haematogenous spread to the lungs is more common, Hatori et al.(2001) 17 have described an alternative route via lymphatic spread to the lungs. Cooperative Osteosarcoma Study Group (COSS) found that patients who presented with unilateral lung metastases have a five-year survival rate of 57% while patients with bilateral lung involvement have a much poorer outcome with five-year survival rate of 20% 18 .
Bone metastases are the second most common site of distant spread. Although joint involvement by osteosarcoma is uncommon because the articular cartilage is a relative barrier to tumour invasion, it can still occur as in the case of our patient with disease metastasising to the right posterior popliteal fossa. Skip lesions are foci of tumour cells within the same bone as the primary lesion but are separated from the primary focus by normal intervening marrow 3 . It is found in 1.4% to 10% of patients [18] [19] [20] [21] . It can be anatomically classified into two types: the intraosseous type and the transarticular type 21 . This patient presented with both types. MRI scans revealed intraosseous involvement of the right femoral neck proximally and transarticular spread to the right proximal tibia. Even radical resectional margins cannot prevent the recurrence of skip lesions. The treatment of choice is still intensive chemotherapy 21 .
The presence of clinically detectable lymph node metastases is uncommon, ranging from 2.3% to 10% of patients 22, 23 . It forebodes a bad prognostic sign and is more common in osteoblastic primary osteosarcoma than in other histologic types 22 . Common sites of distant spread of osteosarcoma to lymph nodes include mediastinal, inguinal, peripancreatic, and retrocrural areas. To the authors' knowledge, simultaneous multiple cervical, supraclavicular, and axillary lymph nodes involvement as seen in this patient's initial presentation have never been reported in literature before.
Metastases of osteosarcoma to subcutaneous fat are extremely rare and only two cases of clinically detectable subcutaneous fat metastases have been reported. Damron et al. (2000) 7 described a case of right distal femur osteosarcoma with a firm and painless lump in the left axillary region at the time of presentation. Kim et al. (2004) 8 reviewed the clinical records of 134 patients treated for osteosarcoma and found one case of subcutaneous fat metastases. At 50 months after the initial diagnosis of left distal femur osteosarcoma, a palpable mass was detected in the right posteromedial thigh 8 . This patient's presentation was even rarer with distant spread to two separate subcutaneous areas -the epigastric region of the anterior abdominal wall and the right gluteal region.
While there are an increasing number of case reports on peritoneal metastases, the authors report the first case of properitoneal fat metastases from osteosarcoma as seen in this patient [24] [25] [26] [27] . Similar to peritoneal metastases, properitoneal fat metastases should be considered as pre-terminal.
The management of osteosarcoma includes neoadjuvant and adjuvant chemotherapy with surgical resection of the primary tumour. Neo-adjuvant chemotherapy can sometimes downsize the primary tumour and eradicate micrometastases. Surgical options for local control include limb salvaging surgery versus amputative resection. This will help to direct post-resectional chemotherapy treatment. Although tumour necrosis of 90% or more is considered good histological response by most physicians, contradictory results in the literature make this cutoff of 90% as a surrogate measure of outcome questionable. While previous studies have shown that good histological response to pre-operative chemotherapy is an important predictive factor of survival [28] [29] [30] [31] [32] [33] [34] , some recent studies suggest otherwise 35, 36 . In a study involving 1,702 patients, 37 showed that post-chemotherapy tumour necrosis has a gradual effect on survival. They concluded that this histological response should not be misinterpreted as an all or nothing phenomenon 37 .
Tumour staging remains an important prognostic indicator. The five-year survival for patients who presented with metastatic disease is 31% 38 . Both metastatic diseases as well as extensive axial lesion involving the right distal femur and proximal tibia, as seen in our patient, confer a poorer prognostic outcome [39] [40] [41] . Similarly, raised alkaline phosphatase and lactate dehydrogenase are also associated with a poorer prognosis 28, [42] [43] [44] .
In summary, distal lymphadenopathy alone is unlikely to raise suspicion towards the diagnosis of lower limb osteosarcoma. Furthermore, the initial presentation of simultaneous multiple
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